Holen Sie sich die Stockscreener-App
4.02
0.99%
-0.04
Handel nachbörslich:
3.92
-0.10
-2.49%
Schlusskurs vom Vortag:
$4.06
Offen:
$4.06
24-Stunden-Volumen:
480.54K
Relative Volume:
1.06
Marktkapitalisierung:
$254.38M
Einnahmen:
$2.72M
Nettoeinkommen (Verlust:
$-85.08M
KGV:
-2.0829
EPS:
-1.93
Netto-Cashflow:
$-70.93M
1W Leistung:
-7.37%
1M Leistung:
+20.00%
6M Leistung:
+375.06%
1J Leistung:
+252.63%
1-Tages-Spanne:
$3.92
$4.135
1-Wochen-Bereich:
$3.92
$4.65
52-Wochen-Spanne:
$0.6922
$4.89
Shattuck Labs Inc Stock (STTK) Company Profile
Firmenname
Shattuck Labs Inc
Sektor
Branche
Telefon
512-900-4690
Adresse
500 W. 5TH STREET, AUSTIN
Vergleichen Sie STTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.02 | 256.92M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Eingeleitet | Wedbush | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-02 | Herabstufung | Needham | Buy → Hold |
| 2024-10-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-31 | Eingeleitet | BTIG Research | Buy |
| 2022-06-01 | Eingeleitet | Citigroup | Buy |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2021-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-03 | Eingeleitet | Citigroup | Buy |
| 2020-11-03 | Eingeleitet | Cowen | Outperform |
| 2020-11-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten
Will DAKT stock hit new highs in YEAR2025 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Shattuck Labs Launches $75 Million At-The-Market Offering - TipRanks
Shattuck Labs Inc enters $75 million common stock sales agreement with Leerink Partners - marketscreener.com
Earnings Risk: Why is Shattuck Labs Inc stock going downJuly 2025 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is Shattuck Labs Inc.’s growth already priced inJuly 2025 Setups & Growth Oriented Trade Recommendations - bollywoodhelpline.com
Resistance Check: Is Shattuck Labs Inc stock a value trapQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Update - Defense World
Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK) - Seeking Alpha
Shattuck Labs (STTK) Price Target Increased by 16.67% to 4.76 - Nasdaq
Shattuck Labs Files $200 Million Mixed Shelf - marketscreener.com
Pullback Watch: Why is Comtech Telecommunications Corp stock going upWeekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
CEO Change: How Shattuck Labs Inc stock reacts to Fed rate cuts2025 Risk Factors & Long Hold Capital Preservation Plans - Bộ Nội Vụ
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How interest rate cuts could boost Shattuck Labs Inc. stockEarnings Performance Report & Free Technical Confirmation Trade Alerts - ulpravda.ru
Will Shattuck Labs Inc. stock gain from lower inflationLong Run Comfort Guide & lightweight options for faster days - Улправда
How Shattuck Labs Inc. stock reacts to global recession fearsJuly 2025 Final Week & AI Enhanced Execution Alerts - Улправда
Can Shattuck Labs Inc. stock attract ESG capital inflowsWeekly Gains Report & Stepwise Entry and Exit Trade Signals - Улправда
Is Shattuck Labs Inc. stock a top pick in earnings seasonBull Run & Weekly Stock Breakout Alerts - Улправда
Individual Investors Are Shattuck Labs, Inc.'s (NASDAQ:STTK) Biggest Owners and Were Rewarded After Market Cap Rose by US$73m Last Week - 富途牛牛
Shattuck Labs (NASDAQ:STTK) Trading 20.6% HigherTime to Buy? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Trading 20.6% Higher – Time to Buy? - Defense World
Does Shattuck Labs Inc. stock trade at a discount to peersRisk Adjusted Returns & You’ve Never Seen Stock Picks Like These - Улправда
Why Shattuck Labs stock soared in December - MSN
Why Madrigal Pharmaceuticals Stock Slumped on Tuesday - AOL.com
Shattuck Labs (STTK): Citigroup Maintains Neutral Rating, Raises Price Target | STTK Stock News - GuruFocus
Shattuck Labs (STTK) Stock Soars 74% Following Analyst Upgrade to Buy - Intellectia AI
Why Shattuck Labs Stock Soared in December - Yahoo Finance
Several Insiders Invested In Shattuck Labs Flagging Positive News - Yahoo Finance
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - MSN
Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - AOL.com
Shattuck Labs Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Why Shattuck Labs Inc. stock is a must watch in 2025Portfolio Update Report & Daily Volume Surge Trade Alerts - Улправда
How Shattuck Labs Inc. stock performs in rate cut cyclesMarket Activity Recap & Daily Profit Maximizing Trade Tips - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Shattuck Labs, Inc. (NASDAQ:STTK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3%Time to Sell? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3% – Time to Sell? - Defense World
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 - Investing News Network
Shattuck Labs announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Shattuck Labs (NASDAQ: STTK) grants 206K inducement options under Rule 5635(c)(4) - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: Shattuck Labs Inc (STTK) - setenews.com
Shattuck Labs (STTK) price target increased by 33.33% to 4.08 - MSN
Shattuck Labs (STTK) Price Target Increased by 33.33% to 4.08 - Nasdaq
What's Next For Shattuck Labs? SL-325 And Bispecific Antibody Programs - RTTNews
Why Shattuck Labs Inc. stock remains undervalued2025 Dividend Review & Weekly Top Performers Watchlists - Newser
STTK: Receptor-targeted TL1A therapy shows promise for safer, more effective treatment and rapid development - TradingView
Shattuck Labs, Inc. (STTK) Slides 8% in Pre-market: Without a Clear Catalyst - Stocks Telegraph
Finanzdaten der Shattuck Labs Inc-Aktie (STTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):